Navigation Links
Antihypertensive treatment on cognitive functions in Alzheimer's disease
Date:7/8/2008

Dementia is one of the major challenges of the 21st century due to the enormous burden these disorders impose on health care systems. Recently, common pathways of the two most frequent causes of dementia, Alzheimers disease and vascular dementia have been suggested. Today there is tremendous interest in developing effective treatments that will interfere with some step in the disease cascade or even prevent the clinical onset of dementia. In the absence of effective therapies, it is essential that all potentially reversible causes of dementia be fully investigated. So far no effective prevention measures can be recommended. During the last decade evidence has accumulated that high blood pressure (hypertension) may be a risk factor for dementia, independent of the presence of cerebrovascular disease. Treatment of hypertension thus might be a key factor in the prevention of cognitive decline and dementia. Dr. Ingmar Skoog, a renowned Swedish researcher in neuroscience from Gteborg University, will evaluate the latest findings about the effect of antihypertensive treatment on cognitive function and dementia and highlight a controversially discussed topic with broad impact on public health in all European countries: Is there hope for the prevention of dementia?


'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
43-140-55734
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1

Related medicine news :

1. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
2. Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
3. New treatment effective in counteracting cocaine-induced symptoms
4. New treatment boosts muscle function in myasthenia gravis
5. Broad-based group of physicians calls for improvement in stroke treatment
6. Cranberry Could Juice Up Ovarian Cancer Treatment
7. Non-medicinal treatment touted for pre-schoolers with ADHD
8. Nonmedicinal treatment touted for preschoolers with ADHD
9. U of M study: Early treatment can reverse heart damage
10. Biologic treatment for rheumatoid arthritis and the risk of cancer
11. New Treatment Explored for Cluster Headaches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... ... and Android devices. VisualDx is the first point of care diagnostic support ... general medicine. The system speeds diagnosis, therapy decisions and patient education for ...
(Date:5/5/2016)... ... ... is just around the corner. Summer means a lot of different things to people. ... all day and night. Parents often lament the coming of summer as they will have ... trips to the beach, backyard cookouts, fireworks on the Fourth of July, and even perhaps ...
(Date:5/5/2016)... ... , ... Dermatologic surgeons performed nearly 10 million medically necessary and cosmetic procedures ... , The results of the 2015 ASDS Survey on Dermatologic Procedures released today reveal ... the growing popularity of soft-tissue fillers and body sculpting procedures. , For the ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... , The Medical Society of Northern Virginia, Announces DoctorsTelemed?, A telehealth ... Medical Society of Northern Virginia (MSNVA) launches DoctorsTelemed?, a telemedicine solution that ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Nepenthe Laboratory Services ... Elementary School last week to raise non-perishable food item donations for Food for Lane ... Day” hosted on NBC. , “The goal of the assembly was to create an ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016  It,s time for an upgrade. There are many medical recorders ... 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix ... a world class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute lymphocytic Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Lymphocytic Leukemia epidemiology, Acute ...
Breaking Medicine Technology: